Association of Ustekinumab Trough Concentrations With Clinical, Biochemical and Endoscopic Outcomes

被引：7
|
作者：
Battat, Robert
Kopylov, Uri
Bessissow, Talat
Bitton, Alain
Cohen, Albert
Martel, Myriam
Seidman, Ernest G.
Afif, Waqqas
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)30587-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
696
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [31] ASSOCIATION OF GOLIMUMAB TROUGH CONCENTRATIONS DURING MAINTENANCE WITH ENDOSCOPIC AND HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS
    Taxonera, Carlos
    Fernandez-Acenero, Maria Jesus
    Olivares, David
    Calvo, Marta
    Casis, Begona
    Bermejo, Fernando
    Lopez, Pilar
    Iborra, Marisa
    Mesonero, Francisco
    Bosca-Watts, Marta Maria
    del Arco, Cristina Diaz
    Vera, Isabel
    Olivares, Sonsoles
    Alba, Cristina
    GASTROENTEROLOGY, 2022, 162 (07) : S807 - S807
  • [32] Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis
    Taxonera Samso, C.
    Fernandez-Acenero, M. J.
    Olivares, D.
    Calvo, M.
    Casis, B.
    Bermejo, F.
    Lopez Serrano, P.
    Iborra, M.
    Mesonero, F.
    Bosca Watts, M.
    Diaz del Arco, C.
    Vera, I.
    Olivares, S.
    Alba, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I323 - I324
  • [33] Voriconazole Steady-State Trough Concentrations and Clinical Outcomes in Patients with Talaromycosis
    Jiang, Zhiwen
    Song, Cong
    Li, Bingkun
    Li, Xiuying
    Yu, Xiaoshu
    Zhou, Siru
    Li, Tiantian
    Huang, Qihua
    Mo, Nanfang
    He, Xiaojuan
    Pang, Qian
    Yao, Zhijian
    Zhou, Changjing
    Cao, Cunwei
    MYCOPATHOLOGIA, 2025, 190 (01)
  • [34] Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease
    Vasudevan, Abhinav
    Tharayil, Vivek
    Raffals, Laura H.
    Bruining, David H.
    Becker, Michelle
    Murad, Mohammad Hassan
    Loftus, Edward, V
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (04) : 660 - 670
  • [35] Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease
    Hisashi Hirayama
    Yasuhiro Morita
    Takayuki Imai
    Kenichiro Takahashi
    Atsushi Yoshida
    Shigeki Bamba
    Osamu Inatomi
    Akira Andoh
    BMC Gastroenterology, 22
  • [36] Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease
    Hirayama, Hisashi
    Morita, Yasuhiro
    Imai, Takayuki
    Takahashi, Kenichiro
    Yoshida, Atsushi
    Bamba, Shigeki
    Inatomi, Osamu
    Andoh, Akira
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [37] The Association between Clinical Response to Ustekinumab and Immunogenicity to Ustekinumab and Prior Adalimumab
    Chiu, Hsien-Yi
    Chu, Thomas Waitao
    Cheng, Yu-Pin
    Tsai, Tsen-Fang
    PLOS ONE, 2015, 10 (11):
  • [38] Association between ustekinumab trough levels and biomarkers in patients with Crohn's disease
    Nicolas de Prado, M. I.
    Iniesta Navalon, C.
    Gomez Espin, R.
    Gil Candel, M.
    Serrano Diaz, L.
    Rentero Redondo, L.
    Martinez Crespo, J. J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S449 - S450
  • [39] Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients
    Di Fonzo, David M. P.
    Alabdulkarim, Balqis
    Yanofsky, Russell
    Abduallah, Yaqeen
    Golovics, Petra
    Lakatos, Peter L.
    Bitton, Alain
    Wild, Gary
    Afif, Waqqas
    Bessissow, Talat
    CROHNS & COLITIS 360, 2024, 6 (04)
  • [40] Therapeutic antibody clearance better predicts endoscopic outcomes than trough concentrations in patients with Crohn's disease
    Wang, Z.
    Hoffert, Y.
    Zhang, W.
    Kantasiripitak, W.
    Verstockt, B.
    Sabino, J.
    Ferrante, M.
    Declerck, P.
    D'Haens, G.
    Laharie, D.
    Vermeire, S.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i24 - i26
12345